Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roivant Sciences NasdaqGS:ROIV |
18,98 B | -17,10% | 2/4 | -76,60% | -913,21% | 30,09% | UP |
|
GW Pharmaceuticals NasdaqGM:GWPH |
6,91 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Centessa Pharmaceuticals NasdaqGS:CNTA |
4,19 B | 0,00% | 0/0 | 0,00% | 0,00% | 32,40% | UP |
|
Abcam NasdaqGM:ABCM |
3,56 B | -48,52% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Genus LSE:GNS |
1,63 B | 1,49% | 4/6 | 13,87% | 15,41% | 33,74% | DOWN |
|
Immunocore Holdings NasdaqGS:IMCR |
1,49 B | 53,28% | 5/6 | 12,68% | 34,74% | 110,60% | DOWN |
|
Oxford Nanopore Technologies LSE:ONT |
1,10 B | -0,86% | 1/5 | 20,55% | 1,62% | 71,05% | DOWN |
|
Oxford Biomedica LSE:OXB |
0,68 B | 5,57% | 1/6 | 35,25% | -59,18% | 43,14% | DOWN |
|
Allergy Therapeutics AIM:AGY |
0,66 B | -37,67% | 0/6 | 0,00% | -894,04% | 30,00% | UP |
|
COMPASS Pathways NasdaqGS:CMPS |
0,69 B | 0,00% | 1/4 | 0,00% | 0,00% | 244,51% | DOWN |
|
Exscientia NasdaqGS:EXAI |
0,63 B | 0,00% | 0/0 | 79,95% | 0,00% | 29,96% | DOWN |
|
Urovant Sciences NasdaqGM:UROV |
0,52 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Orchard Therapeutics NasdaqGM:ORTX |
0,38 B | 0,00% | 4/5 | 81,10% | -9,00% | -100,00% | UP |
|
Autolus Therapeutics NasdaqGS:AUTL |
0,32 B | 53,86% | 2/5 | 76,51% | 91,07% | 643,80% | DOWN |
|
NIOX Group Plc AIM:NIOX |
0,24 B | 23,70% | 5/6 | 48,39% | 17,55% | 41,38% | DOWN |
|
Bicycle Therapeutics NasdaqGS:BCYC |
0,30 B | -7,85% | 0/5 | 2,17% | 57,70% | 85,61% | DOWN |
|
Silence Therapeutics NasdaqGM:SLN |
0,23 B | 46,48% | 2/6 | -87,89% | 63,53% | 407,10% | DOWN |
|
Horizon Discovery Group AIM:HZD |
0,16 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Tiziana Life Sciences Ltd NasdaqCM:TLSA |
0,16 B | 0,00% | 1/4 | 0,00% | 0,00% | 535,48% | DOWN |
|
Scancell Holdings AIM:SCLP |
0,12 B | 0,00% | 2/5 | 0,00% | 0,00% | 158,33% | UP |
